22 August, 2017 by The TZ Newswire Staff Comments Off on Global Exchanges Look at Blockchain Tech
Global Exchanges Look at Blockchain Tech
Non-U.S. exchanges are beginning to examine the practical uses of blockchain and other digital ledger technology (DLT) to boost profitability and increase efficiency.
22 August, 2017 by The TZ Newswire Staff Comments Off on S&P and Nasdaq just can’t turn the technical tide bearish for long
S&P and Nasdaq just can’t turn the technical tide bearish for long
A chink in the armor but can’t get a flesh wound
The Nasdaq fell for thee days coming into today. On Thursday last week, the 50 day MA was busted and there were lower lows and closes on Monday and Tuesday. The low yesterday sniffed the 100 day MA at 6164. Today the open gapped higher,
22 August, 2017 by The TZ Newswire Staff Comments Off on How Herbalife’s share buyback could force Bill Ackman to trim his short position
How Herbalife’s share buyback could force Bill Ackman to trim his short position
Herbalife’s $600 million share buyback will reduce the number of shares available for short sellers to borrow and sharply increase the cost of Ackman’s $1 billion short position.
read more
22 August, 2017 by The TZ Newswire Staff Comments Off on Trump’s Afghanistan strategy is a ‘good first step,’ former ambassador says
Trump’s Afghanistan strategy is a ‘good first step,’ former ambassador says
It will take more than just military action to end the war in Afghanistan, former Ambassador Nancy Soderberg said.
22 August, 2017 by The TZ Newswire Staff Comments Off on What’s the Most Important Drug in Regeneron Pharmaceuticals’ Pipeline?
What’s the Most Important Drug in Regeneron Pharmaceuticals’ Pipeline?
Regeneron Pharmaceuticals (NASDAQ: REGN) has four significant medications on the market, including three that have won Food and Drug Administration approval since 2015, and it’s investing big money in research and development to provide it with a steady stream of new products. One of the most important drugs in its research pipeline is REGN-2810, a cancer-fighting drug that inhibits PD-1 so that cancer can’t hide from the immune system.
22 August, 2017 by The TZ Newswire Staff Comments Off on Could Puerto Rico Be the Next Hot Tax Haven?
Could Puerto Rico Be the Next Hot Tax Haven?
Could Puerto Rico Be the Next Hot Tax Haven?
A loophole may make it a good place for foreigners to keep cash
Some 65,000 Puerto Ricans left their bankrupt U.S. island commonwealth last year. A group of private bankers are moving the other way. They’re increasingly opening offshore banks known as International Financial Entities, which were created by a Puerto Rican law in 2012. There are 44 IFEs now, with 18 opening in the past year, according to data compiled by the…
22 August, 2017 by The TZ Newswire Staff Comments Off on What Will Drive Regeneron Pharmaceuticals’ Growth Higher From Here?
What Will Drive Regeneron Pharmaceuticals’ Growth Higher From Here?
Regeneron Pharmaceuticals‘ (NASDAQ: REGN) $5 billion in sales in 2016 were due mostly to sales of its top-selling vision-restoring drug Eylea. However, a slate of newly Food and Drug Administration-approved drugs could provide significant revenue growth in the coming years. Sales of its bad cholesterol-lowering drug Praluent are starting to pick up, and the eczema drug Dupixent and rheumatoid arthritis drug Kevzara have recently launched.